Latest Healthcare Research Reports

Tag: Preclinical imaging market growth

  • Preclinical Imaging Market Forecast Covering Industry Demand And Market Evolution

    Preclinical Imaging Market Forecast Covering Industry Demand And Market Evolution

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Is The Expected Market Value Outlook For The Preclinical Imaging Market Through 2030?

    The preclinical imaging market has shown significant expansion in recent years. It is projected to increase from $3.69 billion in 2025 to $3.93 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.7%. Historically, this market’s growth was primarily fueled by the increasing utilization of animal models in biomedical research, the broadening scope of oncology and neurology research, a rising adoption of non-invasive imaging techniques, an uptick in preclinical drug testing activities, and the availability of advanced imaging reagents.

    The preclinical imaging market is projected to experience substantial expansion over the upcoming years, anticipated to reach a valuation of $5.18 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. This growth during the forecast period stems from various factors such as the escalating need for real-time disease visualization, increased financial commitments to translational research, the broadening scope of precision medicine studies, the expanding application of AI-assisted image analysis, and the heightened utilization of sophisticated contrast agents. Key trends expected throughout this period include the greater uptake of multi-modal imaging platforms, an increase in the deployment of high-resolution imaging systems, the deepening integration of imaging with data analytics, the enlargement of longitudinal disease monitoring investigations, and a sharpened emphasis on the precision of translational imaging.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

    What Primary Factors Are Fueling The Expansion Of The Preclinical Imaging Market?

    The anticipated rise in chronic diseases is projected to fuel the expansion of the preclinical imaging market in the future. These are defined as prolonged health conditions that endure for an extended duration, generally exceeding three months. Such conditions frequently necessitate continuous medical care and can considerably affect an individual’s quality of life. Preclinical imaging tools are utilized to identify chronic diseases by visualizing aspects like bone structure and lung function. Additionally, these tools aid in studying chronic diseases to observe their progression and enhance comprehension of the conditions. As an illustration, the World Health Organization (WHO), a Switzerland-based international public health agency, reported in February 2024 that non-communicable diseases (NCDs) account for 75% (three-quarters) of all global deaths. Consequently, the growing prevalence of chronic diseases is boosting the preclinical imaging market’s expansion.

    How Does Segment Analysis Break Down The Preclinical Imaging Market Structure?

    The preclinical imaging market covered in this report is segmented –

    1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

    2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

    3) By End User: Hospital, Diagnostics Center, Other End-User

    Subsegments:

    1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging

    2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)

    3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems

    4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems

    5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems

    6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems

    7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging

    What Trends Are Affecting The Growth Of The Preclinical Imaging Market?

    Leading companies in the preclinical CRO market are integrating innovative technologies to sustain their competitive edge, such as employing a disease biology knowledge graph to refine target identification and drug discovery within pharmaceutical research. This knowledge graph offers a structured, extensive depiction of the connections among genes, proteins, pathways, and disease phenotypes, designed to consolidate diverse biological information. It empowers researchers to systematically investigate disease mechanisms, pinpoint potential therapeutic targets, and expedite drug discovery by furnishing a comprehensive overview of disease biology. For example, in February 2023, BenchSci, an AI solutions firm from Canada specializing in preclinical R&D, introduced ASCEND, a comprehensive SaaS platform dedicated to preclinical drug discovery. This platform aims to accelerate preclinical phase drug development pipelines by providing biological insights into the foundational elements of disease. ASCEND utilizes BenchSci’s machine-learning technology to extract experimental data from secure internal and public external sources. The platform then contrasts experimental outcomes against carefully assembled ontology datasets, thereby enabling the software to generate an evidence-based map of the biological processes underpinning various diseases.

    Who Are The Leading Firms Participating In The Preclinical Imaging Market?

    Major companies operating in the preclinical imaging market are Thermo Fisher Scientific Inc, FUJIFILM Visualsonics Inc, Agilent Technologies Inc, PerkinElmer Inc, Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc, Ion Beam Applications SA, Piramal Enterprises Ltd, LI COR Biosciences Inc, Aspect Imaging Ltd, Capintec Inc, Spectral Instruments Inc, Mediso Ltd, MR Solutions Ltd, Biospace Lab SA, Scintica Instrumentation Inc, Trifoil Imaging, Bioscan Inc, Inviscan SAS, Kubtec X Ray, MILabs BV, SCANCO Medical AG, Fujifilm Holdings Corporation

    Access The Complete Preclinical Imaging Market Report:

    https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

    Which Region Accounts For The Highest Share Of The Preclinical Imaging Market?

    North America was the largest region in the preclinical imaging market in 2025. The regions covered in the preclinical imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access Preclinical Imaging Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=12393&type=smp

    Browse Through More Reports Similar to the Global Preclinical Imaging Market 2026, By The Business Research Company

    Healthcare Cro Services Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/healthcare-cro-services-global-market-report

    Crm Bpo Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/crm-bpo-global-market-report

    Veterinary Cro And Cdmo Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Preclinical Imaging Market Overview (2026–2030) With Industry Insights

    Preclinical Imaging Market Overview (2026–2030) With Industry Insights

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Is The Market Size Of The Preclinical Imaging Market Expected To Change From 2026 To 2030?

    The preclinical imaging market size has witnessed strong expansion over recent years. It is anticipated to increase from $3.69 billion in 2025 to $3.93 billion in 2026, at a compound annual growth rate (CAGR) of 6.7%. The surge during the historical period can be ascribed to a greater reliance on animal models in biomedical research, an amplification of oncology and neurology studies, the rising acceptance of non-invasive imaging techniques, an increase in preclinical drug testing endeavors, and the availability of advanced imaging components.

    The preclinical imaging market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $5.18 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. This expansion during the forecast period is primarily driven by factors such as a heightened demand for real-time disease visualization, increasing financial commitments to translational research, the broadening scope of precision medicine studies, the expanding application of AI-assisted image analysis, and the greater deployment of sophisticated contrast agents. Key trends anticipated over this period encompass a wider uptake of multi-modal imaging platforms, an increased utilization of high-resolution imaging systems, deeper integration of imaging technologies with data analytics, an expansion of longitudinal studies for disease monitoring, and a sharpened emphasis on the accuracy of translational imaging.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

    Which Drivers Are Supporting The Preclinical Imaging Market Growth?

    The increasing prevalence of chronic diseases is projected to drive the expansion of the preclinical imaging market moving forward. Chronic diseases are defined as long-term health conditions that persist for an extended duration, typically three months or longer. These ailments frequently demand continuous medical management and can significantly impact an individual’s quality of life. For the identification of chronic diseases, preclinical imaging tools are utilized to visualize elements such as bone structure and lung function. They are also instrumental in studying chronic diseases to observe their progression and deepen understanding. For instance, in February 2024, the World Health Organization (WHO), a Switzerland-based agency overseeing international public health, stated that NCDs are responsible for 75% (three-quarters) of all global deaths. Therefore, the rise in chronic diseases is acting as a significant catalyst for the growth of the preclinical imaging market.

    How Are Segments Identified Within The Preclinical Imaging Market Segment Framework?

    The preclinical imaging market covered in this report is segmented –

    1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

    2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

    3) By End User: Hospital, Diagnostics Center, Other End-User

    Subsegments:

    1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging

    2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)

    3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems

    4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems

    5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems

    6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems

    7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging

    Which Trends Are Expected To Impact The Preclinical Imaging Market?

    Leading companies active in the preclinical imaging market are heightening their emphasis on releasing next-generation imaging systems to secure a competitive advantage. Next-generation imaging systems are defined as sophisticated and groundbreaking technologies that exceed current capacities by integrating cutting-edge features. For example, in September 2023, Revvity Inc., a US-based biotechnology company, introduced next-generation imaging systems crafted to propel innovation across various preclinical research applications. The recently unveiled products encompass the next-generation IVIS Spectrum 2 and the IVIS SpectrumCT 2 imaging systems, the Quantum GX3 microCT imaging solution, and a system that effortlessly combines 2D optical and full 3D imaging. These imaging systems offer enhanced image-based functionalities and are engineered to optimize the imaging workflow.

    Who Are The Companies Competing Within The Preclinical Imaging Market?

    Major companies operating in the preclinical imaging market are Thermo Fisher Scientific Inc, FUJIFILM Visualsonics Inc, Agilent Technologies Inc, PerkinElmer Inc, Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc, Ion Beam Applications SA, Piramal Enterprises Ltd, LI COR Biosciences Inc, Aspect Imaging Ltd, Capintec Inc, Spectral Instruments Inc, Mediso Ltd, MR Solutions Ltd, Biospace Lab SA, Scintica Instrumentation Inc, Trifoil Imaging, Bioscan Inc, Inviscan SAS, Kubtec X Ray, MILabs BV, SCANCO Medical AG, Fujifilm Holdings Corporation

    Get The Full Preclinical Imaging Market Report:

    https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

    Which Region Has The Greatest Market Share In The Preclinical Imaging Market?

    North America was the largest region in the preclinical imaging market in 2025. The regions covered in the preclinical imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Preclinical Imaging Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

    Browse Through More Reports Similar to the Global Preclinical Imaging Market 2026, By The Business Research Company

    Healthcare Cro Services Market Report 2026

    https://www.thebusinessresearchcompany.com/report/healthcare-cro-services-global-market-report

    Crm Bpo Market Report

    https://www.thebusinessresearchcompany.com/report/crm-bpo-global-market-report

    Veterinary Cro And Cdmo Market Report

    https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Preclinical Imaging Market Developments and Growth Opportunities Across 2026–2030

    Preclinical Imaging Market Developments and Growth Opportunities Across 2026–2030

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Value Is Expected For The Preclinical Imaging Market At The End Of The 2026–2030 Forecast Period?

    The preclinical imaging market size has experienced robust expansion over recent years. This market is projected to expand from $3.69 billion in 2025 to $3.93 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.7%. Historically, this expansion has been driven by factors such as the greater utilization of animal models in biomedical research, the enlargement of oncology and neurology research, the increasing acceptance of non-invasive imaging methods, a rise in preclinical drug testing efforts, and the accessibility of sophisticated imaging reagents.

    The preclinical imaging market is anticipated to experience substantial expansion in the coming years, projected to reach $5.18 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. This projected growth is driven by several factors, including heightened demand for real-time disease visualization, increased investments in translational research, the broadening of precision medicine studies, the expanding application of AI-assisted image analysis, and the greater implementation of advanced contrast agents. Concurrently, major trends expected during this period involve the growing embrace of multi-modal imaging platforms, the increased utilization of high-resolution imaging systems, the deeper integration of imaging with data analytics, the enlargement of longitudinal disease monitoring studies, and a sharpened emphasis on translational imaging accuracy.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

    Which Market Drivers Are Supporting The Expansion Of The Preclinical Imaging Market?

    The rising incidence of chronic diseases is projected to drive the growth of the preclinical imaging market in the future. Chronic diseases are long-term health conditions that persist for an extended duration, usually three months or longer. These conditions often require continuous medical management and can significantly impact a person’s quality of life. Preclinical imaging tools are employed to identify chronic diseases through the visualization of bone structure and lung function. They are also used to investigate chronic diseases, allowing researchers to visualize disease progression and enhance understanding. For example, in February 2024, according to the World Health Organization (WHO), a Switzerland-based agency focused on international public health, non-communicable diseases (NCDs) are responsible for 75% (three-quarters) of all deaths worldwide. Consequently, the increasing prevalence of chronic diseases is propelling the expansion of the preclinical imaging market.

    What Segment Types Make Up The Preclinical Imaging Market?

    The preclinical imaging market covered in this report is segmented –

    1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

    2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

    3) By End User: Hospital, Diagnostics Center, Other End-User

    Subsegments:

    1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging

    2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)

    3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems

    4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems

    5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems

    6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems

    7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging

    What Trends Are Affecting The Expansion Of The Preclinical Imaging Market?

    Leading companies within the preclinical imaging market are increasingly focusing on introducing advanced imaging systems to gain a competitive advantage. Next-generation imaging systems denote sophisticated and innovative technologies that extend beyond current capabilities, incorporating cutting-edge features. For example, in September 2023, Revvity Inc., a US-based biotechnology company, released next-generation imaging systems developed to foster innovation across various applications in preclinical research. The new products include the next-generation IVIS Spectrum 2 and the IVIS SpectrumCT 2 imaging systems, the Quantum GX3 microCT imaging solution, and a system that smoothly combines 2D optical and full 3D imaging. These imaging systems offer improved image-based functionalities and are engineered to optimize the imaging workflow.

    Who Are The Key Players Driving Competition In The Preclinical Imaging Market?

    Major companies operating in the preclinical imaging market are Thermo Fisher Scientific Inc, FUJIFILM Visualsonics Inc, Agilent Technologies Inc, PerkinElmer Inc, Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc, Ion Beam Applications SA, Piramal Enterprises Ltd, LI COR Biosciences Inc, Aspect Imaging Ltd, Capintec Inc, Spectral Instruments Inc, Mediso Ltd, MR Solutions Ltd, Biospace Lab SA, Scintica Instrumentation Inc, Trifoil Imaging, Bioscan Inc, Inviscan SAS, Kubtec X Ray, MILabs BV, SCANCO Medical AG, Fujifilm Holdings Corporation

    Read the full preclinical imaging market report here:

    https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

    How Is The Preclinical Imaging Market Distributed Across Key Geographic Regions?

    North America was the largest region in the preclinical imaging market in 2025. The regions covered in the preclinical imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Preclinical Imaging Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=12393&type=smp

    Browse Through More Reports Similar to the Global Preclinical Imaging Market 2026, By The Business Research Company

    Healthcare Cro Services Global Market Report

    https://www.thebusinessresearchcompany.com/report/healthcare-cro-services-global-market-report

    Crm Bpo Global Market Report

    https://www.thebusinessresearchcompany.com/report/crm-bpo-global-market-report

    Veterinary Cro And Cdmo Global Market Report

    https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Preclinical Imaging Market Size and Demand Forecast 2026–2030

    Preclinical Imaging Market Size and Demand Forecast 2026–2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the preclinical imaging market from 2026–2035 with trusted insights from The Business Research Company

    How much is the Preclinical Imaging Market valued at in 2026, and what valuation is forecast for 2030?

    The preclinical imaging market has experienced robust growth in recent years. It is projected to expand from $3.69 billion in 2025 to $3.93 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. This historical growth can be attributed to several factors, including the increasing application of animal models in biomedical research, the expansion of oncology and neurology research, the rising acceptance of non-invasive imaging techniques, the growth in preclinical drug testing activities, and the availability of advanced imaging reagents.

    The preclinical imaging market size is forecast to experience significant expansion over the next few years, with its value expected to reach $5.18 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. This projected growth throughout the forecast period stems from factors such as the rising demand for real-time disease visualization, increased investments in translational research, the broadening scope of precision medicine studies, the expanding application of AI-assisted image analysis, and the growing deployment of advanced contrast agents. Prominent trends anticipated during this period include the increased adoption of multi-modal imaging platforms, a rise in the use of high-resolution imaging systems, the growing integration of imaging with data analytics, the expansion of longitudinal disease monitoring studies, and an enhanced focus on translational imaging accuracy.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

    What Drivers Are Influencing The Growth Of The Preclinical Imaging Market?

    The future expansion of the preclinical imaging market is anticipated to be driven by the rising prevalence of chronic diseases. These conditions are defined as long-lasting health issues typically enduring for at least three months, frequently necessitating continuous medical care, and capable of profoundly affecting an individual’s quality of life. Preclinical imaging instruments are employed to identify chronic diseases by visualizing aspects such as bone structure and lung function. Additionally, these tools aid in studying chronic diseases, allowing for visualization of disease progression and enhancing comprehension. For example, data from February 2024 published by the World Health Organization (WHO), the international public health agency based in Switzerland, indicated that NCDs account for 75% (three-quarters) of global deaths. Consequently, the escalating burden of chronic diseases is fueling the expansion of the preclinical imaging market.

    How Is The Preclinical Imaging Market Organized Into Various Segments?

    The preclinical imaging market covered in this report is segmented –

    1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

    2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

    3) By End User: Hospital, Diagnostics Center, Other End-User

    Subsegments:

    1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging

    2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)

    3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems

    4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems

    5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems

    6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems

    7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging

    How Are Emerging Trends Affecting The Progression Of The Preclinical Imaging Market?

    Major companies in the preclinical imaging market are increasingly focusing on introducing next-generation imaging systems to secure a competitive edge. These next-generation systems embody advanced and innovative technologies that extend beyond current capabilities, incorporating cutting-edge features. For instance, in September 2023, Revvity Inc., a US-based biotechnology company, unveiled next-generation imaging systems engineered to propel innovation across various applications in preclinical research. The recently launched products feature the next-generation IVIS Spectrum 2 and IVIS SpectrumCT 2 imaging systems, the Quantum GX3 microCT imaging solution, and a system that effortlessly combines 2D optical and full 3D imaging. These advanced imaging systems are characterized by improved image-based capabilities and are designed to streamline the imaging workflow.

    Who Are The Core Companies Influencing Trends In The Preclinical Imaging Market?

    Major companies operating in the preclinical imaging market are Thermo Fisher Scientific Inc, FUJIFILM Visualsonics Inc, Agilent Technologies Inc, PerkinElmer Inc, Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc, Ion Beam Applications SA, Piramal Enterprises Ltd, LI COR Biosciences Inc, Aspect Imaging Ltd, Capintec Inc, Spectral Instruments Inc, Mediso Ltd, MR Solutions Ltd, Biospace Lab SA, Scintica Instrumentation Inc, Trifoil Imaging, Bioscan Inc, Inviscan SAS, Kubtec X Ray, MILabs BV, SCANCO Medical AG, Fujifilm Holdings Corporation

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

    Which Regions Are Projected To Dominate The Preclinical Imaging Market In The Coming Years?

    North America was the largest region in the preclinical imaging market in 2025. The regions covered in the preclinical imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Preclinical Imaging Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=12393&type=smp

    Browse Through More Reports Similar to the Global Preclinical Imaging Market 2026, By The Business Research Company

    Clinical Trial Imaging Market Report 2026

    https://www.thebusinessresearchcompany.com/report/clinical-trial-imaging-global-market-report

    Medical Imaging Market Report 2026

    https://www.thebusinessresearchcompany.com/report/medical-imaging-global-market-report

    Pediatric Imaging Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pediatric-imaging-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Preclinical Imaging Market Size and Demand Forecast 2026–2030

    Preclinical Imaging Market Size and Demand Forecast 2026–2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the preclinical imaging market from 2026–2035 with trusted insights from The Business Research Company

    How much is the Preclinical Imaging Market valued at in 2026, and what valuation is forecast for 2030?

    The preclinical imaging market has experienced robust growth in recent years. It is projected to expand from $3.69 billion in 2025 to $3.93 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. This historical growth can be attributed to several factors, including the increasing application of animal models in biomedical research, the expansion of oncology and neurology research, the rising acceptance of non-invasive imaging techniques, the growth in preclinical drug testing activities, and the availability of advanced imaging reagents.

    The preclinical imaging market size is forecast to experience significant expansion over the next few years, with its value expected to reach $5.18 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. This projected growth throughout the forecast period stems from factors such as the rising demand for real-time disease visualization, increased investments in translational research, the broadening scope of precision medicine studies, the expanding application of AI-assisted image analysis, and the growing deployment of advanced contrast agents. Prominent trends anticipated during this period include the increased adoption of multi-modal imaging platforms, a rise in the use of high-resolution imaging systems, the growing integration of imaging with data analytics, the expansion of longitudinal disease monitoring studies, and an enhanced focus on translational imaging accuracy.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

    What Drivers Are Influencing The Growth Of The Preclinical Imaging Market?

    The future expansion of the preclinical imaging market is anticipated to be driven by the rising prevalence of chronic diseases. These conditions are defined as long-lasting health issues typically enduring for at least three months, frequently necessitating continuous medical care, and capable of profoundly affecting an individual’s quality of life. Preclinical imaging instruments are employed to identify chronic diseases by visualizing aspects such as bone structure and lung function. Additionally, these tools aid in studying chronic diseases, allowing for visualization of disease progression and enhancing comprehension. For example, data from February 2024 published by the World Health Organization (WHO), the international public health agency based in Switzerland, indicated that NCDs account for 75% (three-quarters) of global deaths. Consequently, the escalating burden of chronic diseases is fueling the expansion of the preclinical imaging market.

    How Is The Preclinical Imaging Market Organized Into Various Segments?

    The preclinical imaging market covered in this report is segmented –

    1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

    2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

    3) By End User: Hospital, Diagnostics Center, Other End-User

    Subsegments:

    1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging

    2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)

    3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems

    4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems

    5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems

    6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems

    7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging

    How Are Emerging Trends Affecting The Progression Of The Preclinical Imaging Market?

    Major companies in the preclinical imaging market are increasingly focusing on introducing next-generation imaging systems to secure a competitive edge. These next-generation systems embody advanced and innovative technologies that extend beyond current capabilities, incorporating cutting-edge features. For instance, in September 2023, Revvity Inc., a US-based biotechnology company, unveiled next-generation imaging systems engineered to propel innovation across various applications in preclinical research. The recently launched products feature the next-generation IVIS Spectrum 2 and IVIS SpectrumCT 2 imaging systems, the Quantum GX3 microCT imaging solution, and a system that effortlessly combines 2D optical and full 3D imaging. These advanced imaging systems are characterized by improved image-based capabilities and are designed to streamline the imaging workflow.

    Who Are The Core Companies Influencing Trends In The Preclinical Imaging Market?

    Major companies operating in the preclinical imaging market are Thermo Fisher Scientific Inc, FUJIFILM Visualsonics Inc, Agilent Technologies Inc, PerkinElmer Inc, Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc, Ion Beam Applications SA, Piramal Enterprises Ltd, LI COR Biosciences Inc, Aspect Imaging Ltd, Capintec Inc, Spectral Instruments Inc, Mediso Ltd, MR Solutions Ltd, Biospace Lab SA, Scintica Instrumentation Inc, Trifoil Imaging, Bioscan Inc, Inviscan SAS, Kubtec X Ray, MILabs BV, SCANCO Medical AG, Fujifilm Holdings Corporation

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

    Which Regions Are Projected To Dominate The Preclinical Imaging Market In The Coming Years?

    North America was the largest region in the preclinical imaging market in 2025. The regions covered in the preclinical imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Preclinical Imaging Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=12393&type=smp

    Browse Through More Reports Similar to the Global Preclinical Imaging Market 2026, By The Business Research Company

    Clinical Trial Imaging Market Report 2026

    https://www.thebusinessresearchcompany.com/report/clinical-trial-imaging-global-market-report

    Medical Imaging Market Report 2026

    https://www.thebusinessresearchcompany.com/report/medical-imaging-global-market-report

    Pediatric Imaging Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pediatric-imaging-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Preclinical Imaging Market Size and Demand Forecast 2026–2030

    Preclinical Imaging Market Size and Demand Forecast 2026–2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the preclinical imaging market from 2026–2035 with trusted insights from The Business Research Company

    How much is the Preclinical Imaging Market valued at in 2026, and what valuation is forecast for 2030?

    The preclinical imaging market has experienced robust growth in recent years. It is projected to expand from $3.69 billion in 2025 to $3.93 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. This historical growth can be attributed to several factors, including the increasing application of animal models in biomedical research, the expansion of oncology and neurology research, the rising acceptance of non-invasive imaging techniques, the growth in preclinical drug testing activities, and the availability of advanced imaging reagents.

    The preclinical imaging market size is forecast to experience significant expansion over the next few years, with its value expected to reach $5.18 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. This projected growth throughout the forecast period stems from factors such as the rising demand for real-time disease visualization, increased investments in translational research, the broadening scope of precision medicine studies, the expanding application of AI-assisted image analysis, and the growing deployment of advanced contrast agents. Prominent trends anticipated during this period include the increased adoption of multi-modal imaging platforms, a rise in the use of high-resolution imaging systems, the growing integration of imaging with data analytics, the expansion of longitudinal disease monitoring studies, and an enhanced focus on translational imaging accuracy.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

    What Drivers Are Influencing The Growth Of The Preclinical Imaging Market?

    The future expansion of the preclinical imaging market is anticipated to be driven by the rising prevalence of chronic diseases. These conditions are defined as long-lasting health issues typically enduring for at least three months, frequently necessitating continuous medical care, and capable of profoundly affecting an individual’s quality of life. Preclinical imaging instruments are employed to identify chronic diseases by visualizing aspects such as bone structure and lung function. Additionally, these tools aid in studying chronic diseases, allowing for visualization of disease progression and enhancing comprehension. For example, data from February 2024 published by the World Health Organization (WHO), the international public health agency based in Switzerland, indicated that NCDs account for 75% (three-quarters) of global deaths. Consequently, the escalating burden of chronic diseases is fueling the expansion of the preclinical imaging market.

    How Is The Preclinical Imaging Market Organized Into Various Segments?

    The preclinical imaging market covered in this report is segmented –

    1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

    2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

    3) By End User: Hospital, Diagnostics Center, Other End-User

    Subsegments:

    1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging

    2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)

    3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems

    4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems

    5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems

    6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems

    7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging

    How Are Emerging Trends Affecting The Progression Of The Preclinical Imaging Market?

    Major companies in the preclinical imaging market are increasingly focusing on introducing next-generation imaging systems to secure a competitive edge. These next-generation systems embody advanced and innovative technologies that extend beyond current capabilities, incorporating cutting-edge features. For instance, in September 2023, Revvity Inc., a US-based biotechnology company, unveiled next-generation imaging systems engineered to propel innovation across various applications in preclinical research. The recently launched products feature the next-generation IVIS Spectrum 2 and IVIS SpectrumCT 2 imaging systems, the Quantum GX3 microCT imaging solution, and a system that effortlessly combines 2D optical and full 3D imaging. These advanced imaging systems are characterized by improved image-based capabilities and are designed to streamline the imaging workflow.

    Who Are The Core Companies Influencing Trends In The Preclinical Imaging Market?

    Major companies operating in the preclinical imaging market are Thermo Fisher Scientific Inc, FUJIFILM Visualsonics Inc, Agilent Technologies Inc, PerkinElmer Inc, Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc, Ion Beam Applications SA, Piramal Enterprises Ltd, LI COR Biosciences Inc, Aspect Imaging Ltd, Capintec Inc, Spectral Instruments Inc, Mediso Ltd, MR Solutions Ltd, Biospace Lab SA, Scintica Instrumentation Inc, Trifoil Imaging, Bioscan Inc, Inviscan SAS, Kubtec X Ray, MILabs BV, SCANCO Medical AG, Fujifilm Holdings Corporation

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

    Which Regions Are Projected To Dominate The Preclinical Imaging Market In The Coming Years?

    North America was the largest region in the preclinical imaging market in 2025. The regions covered in the preclinical imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Preclinical Imaging Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=12393&type=smp

    Browse Through More Reports Similar to the Global Preclinical Imaging Market 2026, By The Business Research Company

    Clinical Trial Imaging Market Report 2026

    https://www.thebusinessresearchcompany.com/report/clinical-trial-imaging-global-market-report

    Medical Imaging Market Report 2026

    https://www.thebusinessresearchcompany.com/report/medical-imaging-global-market-report

    Pediatric Imaging Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pediatric-imaging-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Preclinical Imaging Market Key Insights 2024-2033: Growth Rate, Trends And Opportunities

    Preclinical Imaging Market Key Insights 2024-2033: Growth Rate, Trends And Opportunities

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Projected Growth Rate of the Preclinical Imaging Market from 2024 to 2033?

    The size of the preclinical imaging market has seen substantial growth over the recent years. An increase from $3.2 billion in 2023 to $3.44 billion in 2024 is predicted, with a compound annual growth rate (CAGR) of 7.4%. The expansion seen in the past can be credited to governmental initiatives, increase in illnesses, evolving applications, heightened consciousness, and the growth of emerging markets.

    In the upcoming years, the preclinical imaging market is projected to experience robust growth. It is estimated to reach $4.42 billion in 2028, with a compound annual growth rate (CAGR) of 6.5%. Factors contributing to its growth during the forecast period include the adoption of personalized medicine, progress in molecular imaging, outsourcing of drug development, regulatory support, and escalating chronic diseases. The major trends forecasted for this period involve green imaging technologies, advancements in technology, increase in research and development activities, collaborations, partnerships, and real-time imaging.

    Claim Your Free Sample of the Global Preclinical Imaging Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

    What Are the Key Drivers of Growth in the preclinical imaging Market?

    The rise in persistent health conditions is anticipated to foster the expansion of the preclinical imaging market in the future. These persistent conditions, often known as chronic diseases, are long-term health issues that tend to last for a minimum of three months or even more. Such illnesses frequently require consistent medical supervision and can considerably affect an individual’s lifestyle. To detect these chronic diseases, tools like preclinical imaging are employed to display the skeletal structure and functionality of the lungs. It is also utilized to analyze chronic diseases, facilitating the visualization of disease progression and enhancing understanding of the illness. For illustration, the World Health Organization’s (WHO) 2022 Highlights in September 2022 stated that there were 41 million deaths worldwide, representing 74% of all deaths caused by noncommunicable or chronic diseases. This number includes 17.9 million deaths due to cardiovascular diseases, 9.3 million due to cancer, 4.1 million due to chronic respiratory diseases, and 2.0 million due to diabetes. Thus, the escalating incidence of chronic disease is propelling the growth of the preclinical imaging market.

    What Are the Notable Segments in the Preclinical Imaging Market?

    1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

    2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

    3) By End User: Hospital, Diagnostics Center, Other End-User

    Which Emerging Trends Are Altering the Preclinical Imaging Market?

    Gaining traction in the preclinical imaging market is the trend of product innovations. To maintain their standing in the market, leading companies in this sector are producing novel products. For instance, Fujifilm VisualSonics Inc., a Canadian biomedical company specializing in imaging system production, launched Vevo F2, an innovative product for preclinical imaging, in May 2022. The Vevo F2 is the first ultrasonic and photoacoustic imaging system to take preclinical imaging frequencies ranging from ultra-high at 71 MHz to low at 1 MHz. This state-of-the-art equipment touts HD image processing technology and a novel signal pathway, promising superior image clarity and stronger frame rates. It can be tailored to the specific accuracy requirements of imaging and has a variety of features such as a wide range of anatomical targets and high-resolution imaging. It is apt for a multitude of research applications.

    Order Now for Fast Delivery of Your Preclinical Imaging Market Report!

    https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

    Which Regions Are Most Influential in Expanding the Preclinical Imaging Market?

    North America was the largest region in the preclinical imaging market in 2023. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Preclinical Imaging Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the preclinical imaging market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Preclinical Imaging Market Include

    1. Preclinical Imaging Market Executive Summary

    2. Preclinical Imaging Market Segments

    3. Preclinical Imaging Market Size And Template Market Growth Rate

    4. Key Preclinical Imaging Market Trends

    5. Major Preclinical Imaging Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Preclinical Imaging Market

    26. Top Preclinical Imaging Companies

    27. Preclinical Imaging Market Opportunities And Strategies

    28. Preclinical Imaging Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Pediatric Clinical Trials Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/pediatric-clinical-trials-global-market-report

    Virtual Clinical Trials Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

    Artificial Intelligence Services Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-services-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Comprehensive Analysis On Size, Share, And Drivers Of The Preclinical Imaging Market

    Comprehensive Analysis On Size, Share, And Drivers Of The Preclinical Imaging Market

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    Product Innovations Drive Market Growth

    • Companies are investing in innovative products to maintain market position.
    • Example: Fujifilm VisualSonics Inc. introduced Vevo F2, an advanced preclinical imaging system.
    • Vevo F2 features customizable architecture, high-definition image processing, and versatile applications.

    Rigaku Corporation’s Strategic Acquisition Expands Market Reach

    • Rigaku Corporation’s acquisition of MILabs B.V. aims to strengthen its presence in life sciences.
    • MILabs B.V. specializes in manufacturing preclinical imaging systems for diverse research domains.
    • This acquisition enhances Rigaku Corporation’s research and development capabilities.

    View More On The Preclinical Imaging Market Report 2024 – https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

    Segmentation of the Preclinical Imaging Market

    1. By Modality
      • Optical Imaging Systems
      • Preclinical Nuclear Imaging Systems
      • Micro-magnetic Resonance Imaging Systems
      • Micro-Ultrasound Systems
      • Micro-computed Tomography Systems
      • Preclinical Photoacoustic Imaging Systems
      • Preclinical Magnetic Particle Imaging (MPI) Systems
    2. By Reagents
      • Preclinical Optical Imaging Reagents
      • Preclinical Nuclear Imaging Reagents
      • Preclinical MRI Contrast Agents
      • Preclinical Ultrasound Contrast Agents
      • Preclinical CT Contrast Agents
    3. By End User
      • Hospital
      • Diagnostics Center
      • Other End-User

    Rising Chronic Disease Burden Fuels Preclinical Imaging Market Growth

    Significance of Preclinical Imaging in Chronic Disease Management

    • Preclinical imaging facilitates the visualization of disease progression and treatment efficacy.
    • Chronic diseases, such as cardiovascular diseases, cancer, respiratory diseases, and diabetes, contribute significantly to global mortality rates.
    • Preclinical imaging tools aid in understanding chronic diseases, thereby driving market growth.

    Government Initiatives and Technological Advancements Propel Market Expansion

    • Government initiatives aimed at disease prevention and management bolster the demand for preclinical imaging.
    • Technological advancements enhance imaging accuracy and efficiency, fostering market growth.
    • Collaborations and partnerships among industry players stimulate innovation in preclinical imaging technologies.

    Forecasted Growth and Market Trends

    Promising Growth Prospects in the Forecast Period

    • The preclinical imaging market is projected to reach $4.42 billion by 2028, with a CAGR of 6.5%.
    • Factors driving growth include personalized medicine adoption and drug development outsourcing.

    Emerging Trends in the Preclinical Imaging Market

    • Green imaging technologies gain traction due to environmental concerns.
    • Increasing R&D activities propel innovation in preclinical imaging systems.
    • Real-time imaging capabilities offer new avenues for research and diagnosis.

    Conclusion

    The preclinical imaging market demonstrates robust growth prospects driven by factors such as rising chronic disease prevalence, technological advancements, and strategic collaborations. Innovations in imaging systems and reagents cater to diverse research needs, while market segmentation facilitates targeted strategies. As the market continues to evolve, stakeholders must adapt to emerging trends to capitalize on growth opportunities and contribute to advancements in healthcare and research.

    Request A Sample Of The Global Preclinical Imaging Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=12393&type=smp